LORI JAMES: Open Payments
NPI 1114065398 · COLUMBIA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 16 payments from 11 companies in 2025. Trend: 2023 $325 · 2024 $437 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Novo Nordisk Inc | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Amgen Inc. | 2 | $32 |
| Corcept Therapeutics | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: AIRSUPRA, Ozempic, GEMTESA, QULIPTA, OTEZLA, UBRELVY, Korlym, CAPLYTA.
Industry payments across TN — which companies pay providers there.
